Circulating endothelial progenitor cells in cardiovascular disorders.
Dael Geft1, Shmuel Schwartzenberg, Jacob George
1daelgeft@hotmail.com
Expert Review of Cardiovascular Therapy
|September 17, 2008
Summary
Endothelial progenitor cells (EPCs) play a crucial role in vascular repair but are often impaired by cardiovascular risk factors. Understanding EPCs offers potential for diagnosing and treating cardiovascular diseases.
Area of Science:
- Cardiovascular Biology
- Regenerative Medicine
- Endothelial Cell Biology
Background:
- The vascular endothelium is vital in cardiovascular health and disease.
- Mature endothelial cells have limited capacity for repairing vascular injury.
- Circulating endothelial progenitor cells (EPCs) are increasingly recognized for their role in vascular repair and neovascularization.
Purpose of the Study:
- To provide an overview of human endothelial progenitor cells (EPCs).
- To discuss EPC assessment methods, quantification, and functional properties in cardiovascular conditions.
- To explore the potential diagnostic and therapeutic applications of EPCs.
Main Methods:
- Review of recent scientific literature on EPCs.
- Analysis of EPC assessment techniques and quantification methods.
- Examination of EPC function in various cardiovascular disease states.
Main Results:
- EPC number and function are significantly impacted by cardiovascular risk factors and disease states.
- EPCs are critical for vascular healing, repair, and postnatal neovascularization.
- Current research highlights the variability in EPC assessment and function.
Conclusions:
- EPCs represent a promising area for understanding and managing cardiovascular disorders.
- Further research into EPCs could lead to novel diagnostic biomarkers and therapeutic strategies.
- Understanding EPC dysfunction is key to addressing cardiovascular disease progression.
Related Concept Videos
Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...


